Vaccine News and Research

Latest Vaccine News and Research

Volunteer nurse back in isolation with Ebola complications

This morning Pauline Cafferkey, the nurse who survived infection with the Ebola virus, was airlifted to an isolation unit at the Royal Free Hospital in London after the Ebola virus was detected in blood samples.

9 Oct 2015

UNC researchers identify a type of vaginal bacteria that can protect women from HIV

Researchers at the University of North Carolina at Chapel Hill have identified a type of vaginal bacteria within the mucus of the female reproductive system that can protect women from HIV as well as other sexually transmitted infections.

9 Oct 2015

Invasive Salmonella infections revealed as major cause of child illness and deaths in Africa

Invasive Salmonella infections in sub-Saharan Africa are a major cause of child illness and deaths, a new body of research into this usually overlooked infectious disease has revealed.

8 Oct 2015

Wake Forest Baptist Medical Center announces creation of Technology Development Program

Wake Forest Baptist Medical Center today announced the creation of a Technology Development Program, a $15 million program to develop the ideas, discoveries and inventions of the faculty and staff of the Medical Center into life science technologies having the potential to benefit patients in the community and worldwide.

8 Oct 2015

Genocea announces positive data in Phase 2 trial evaluating GEN-003 for the treatment of genital herpes

Genocea Biosciences, Inc. (NASDAQ:GNCA), a biopharmaceutical company developing T cell-directed vaccines and immunotherapies, has announced positive results from a planned interim analysis of data collected six months after dosing from its ongoing Phase 2 dose optimization trial evaluating GEN-003 for the treatment of genital herpes. At its best performing dose of 60 µg per protein / 75 µg of Matrix-M2TM adjuvant, GEN-003 demonstrated a statistically significant 58 percent reduction from baseline in the viral shedding rate (p < 0.0001), the primary endpoint of the study.

7 Oct 2015

Provepep synthesizes bioactive homodimer form of IL-10 using SEA peptide ligation technology

Provepep, the peptide business unit of Provence Technologies Group, a specialist fine chemistry research group, today announces that it has successfully synthesized tens of mg of bioactive homodimer form of IL-10.

7 Oct 2015

NS1 protein can be considered as vital target for development of new drugs to treat dengue: Study

Dengue is a mosquito-borne tropical disease currently endemic in more than 10 countries. According to the World Health Organization, 390 million people are infected by dengue every year.

7 Oct 2015

Influenza-related pneumonia hospitalizations could be prevented through influenza vaccination

More than half of hospitalizations due to influenza pneumonia could be prevented by influenza vaccination, according to a study led by investigators at Vanderbilt University Medical Center, published this week in the Journal of the American Medical Association.

7 Oct 2015

Researchers find link between El Niño and dengue epidemics

Epidemics of dengue are linked to high temperatures brought by the El Niño weather phenomenon, a University of Florida scientist working with an international team of researchers has found.

7 Oct 2015

Flu vaccine significantly reduces stroke risk

The risk of suffering a stroke is significantly reduced for up to two months after receiving a flu vaccine, a major new study has shown.

6 Oct 2015

Vaccination against type 1 diabetes may soon be available to young children

A vaccination against type 1 diabetes will soon also be available to young children: the Pre-POINTearly vaccination study will involve children between the ages of six months and two years from across Germany who have a first-degree relative with type 1 diabetes.

6 Oct 2015

UT Southwestern announces launch of new health initiative

UT Southwestern Medical Center today announced the launch of "Call Out Cancer," a new health initiative designed to promote awareness, early detection, and prevention of all types of cancer.

6 Oct 2015

Patients with influenza-associated pneumonia less likely to receive influenza vaccine: Study

Among children and adults hospitalized with community-acquired pneumonia, those with influenza-associated pneumonia, compared with those with pneumonia not associated with influenza, had lower odds of having received an influenza vaccination, according to a study published online by JAMA.

6 Oct 2015

Missouri schools underprepared for pandemics, natural disasters and bioterrorism attacks

Missouri schools are no more prepared to respond to pandemics, natural disasters, and bioterrorism attacks than they were in 2011, according to a study published in the October issue of the American Journal of Infection Control, the official publication of the Association for Professionals in Infection Control and Epidemiology.

6 Oct 2015

Testosterone therapy not associated with increased risk of aggressive prostate cancer: Study

A new population-based study from The University of Texas Medical Branch at Galveston showed for the first time that exposure to testosterone therapy over a five-year period was not associated with an increased risk of aggressive prostate cancer. Further, risk of high-grade prostate cancer did not increase according to the total number of testosterone injections.

5 Oct 2015

Researchers identify new gene locus that may protect children from developing malaria in Africa

Published today in Nature, the findings detail a new gene locus that can explain why, in communities where everyone is constantly exposed to malaria, some children develop severe malaria and others don't. Now, researchers can be sure that this particular stretch of our DNA plays a crucial role in the progression of the disease.

1 Oct 2015

Generex agrees to acquire 51% equity interest in Hema Diagnostic Systems

Generex Biotechnology Corporation today announced that it has entered into a non-binding Letter of Intent (LOI) with Hema Diagnostic Systems, LLC (HDS), a Florida company that designs and manufactures proprietary infectious disease detection technologies.

30 Sep 2015

Tunitas Therapeutics completes $10 million Series A venture financing

Tunitas Therapeutics, Inc. today announced the close of a $10 million Series A venture financing. The financing was co-led by Ally Bridge Group and WuXi Ventures, with the further participation of RA Capital Advisors.

30 Sep 2015

BiondVax to begin Phase IIb clinical trial of universal influenza vaccine in Europe

BiondVax Pharmaceuticals Ltd. announced today that it received regulatory clearance from the Hungarian Regulatory Authority (National Institute of Pharmacology and Nutrition, OGYEI) and the Central Ethics Committee in Budapest to initiate a Phase IIb clinical trial. The initiation meeting was scheduled for today, September 30, 2015, together with the partners from the UNISEC European Consortium.

30 Sep 2015

Unique molecule can bind HIV-infected cells to killer T cells

A unique molecule developed at Duke Medicine, the University of North Carolina at Chapel Hill and MacroGenics, Inc., is able to bind HIV-infected cells to the immune system's killer T cells. It could become a key part of a shock-and-kill strategy being developed in the hope of one day clearing HIV infection.

29 Sep 2015

Vaccine News and Research

Latest Vaccine News and Research

Volunteer nurse back in isolation with Ebola complications

UNC researchers identify a type of vaginal bacteria that can protect women from HIV

Invasive Salmonella infections revealed as major cause of child illness and deaths in Africa

Wake Forest Baptist Medical Center announces creation of Technology Development Program

Genocea announces positive data in Phase 2 trial evaluating GEN-003 for the treatment of genital herpes

Provepep synthesizes bioactive homodimer form of IL-10 using SEA peptide ligation technology

NS1 protein can be considered as vital target for development of new drugs to treat dengue: Study

Influenza-related pneumonia hospitalizations could be prevented through influenza vaccination

Researchers find link between El Niño and dengue epidemics

Flu vaccine significantly reduces stroke risk

Vaccination against type 1 diabetes may soon be available to young children

UT Southwestern announces launch of new health initiative

Patients with influenza-associated pneumonia less likely to receive influenza vaccine: Study

Missouri schools underprepared for pandemics, natural disasters and bioterrorism attacks

Testosterone therapy not associated with increased risk of aggressive prostate cancer: Study

Researchers identify new gene locus that may protect children from developing malaria in Africa

Generex agrees to acquire 51% equity interest in Hema Diagnostic Systems

Tunitas Therapeutics completes $10 million Series A venture financing

BiondVax to begin Phase IIb clinical trial of universal influenza vaccine in Europe

Unique molecule can bind HIV-infected cells to killer T cells

Event guide: 3rd mRNA Process Development & Manufacturing Europe eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Vaccine News and Research

Latest Vaccine News and Research

Event guide: 3rd mRNA Process Development & Manufacturing Europe eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Newsletters you may be interested in